View Older Stories

May 21, 2026 07:00AM Natera expands Austin operations, plans what it calls world's largest sequencing facility

May 20, 2026 07:02AM Natera's fetal genetic testing trial enrolls over 2,000 patients

May 15, 2026 12:55PM FDA approves Natera's Signatera CDx for bladder cancer treatment decisions

May 15, 2026 12:32PM FDA approves Genentech's Tecentriq for bladder cancer treatment

May 11, 2026 08:45AM Natera (NTRA) PT Lowered to $250 at BTIG

May 7, 2026 04:42PM Natera (NTRA) Misses Q1 EPS by 6c; raises guidance

Apr 28, 2026 09:18AM Barclays: Life science insiders sold $187M in stock during first quarter

Apr 13, 2026 04:02PM William Blair Starts Natera (NTRA) at Outperform

Apr 9, 2026 06:00AM Court awards Natera 30% ongoing royalty in patent dispute

Apr 7, 2026 05:22AM Citi Adjusts Catalyst Watch List

Mar 16, 2026 06:01AM Natera studies show Signatera test predicts cancer recurrence risk

Mar 2, 2026 05:47PM Natera (NTRA) PT Lowered to $250 at Morgan Stanley

Mar 2, 2026 11:06AM Canaccord Reiterates Buy Rating on Natera (NTRA) following Q4

Feb 26, 2026 04:22PM Natera (NTRA) Reports Q4 results

Feb 26, 2026 03:19PM Natera (NTRA) spreader of 1900 contracts of March 175 puts and 1900 contracts of March 200 puts

Feb 17, 2026 08:30AM Piper Sandler Highlights 'A Number of Growth Opportunities' at Natera (NTRA)

Feb 2, 2026 06:01AM Natera submits bladder cancer diagnostic test to FDA for approval

Jan 28, 2026 08:01AM Natera completes enrollment in heart transplant trial testing blood-based monitoring

Jan 21, 2026 06:00AM Natera publishes validation study for colorectal cancer test

Jan 20, 2026 06:02AM Natera's prenatal test selected for plenary presentation at medical meeting

Jan 13, 2026 08:02AM Natera develops AI model to enhance cancer risk assessment

Jan 12, 2026 05:35AM Canaccord Genuity Reiterates Buy Rating on Natera (NTRA)

Jan 12, 2026 04:06AM Natera reports preliminary 2025 revenue growth of 35% to $2.3 billion

Jan 7, 2026 05:01AM Citi Starts Natera (NTRA) at Buy

Jan 6, 2026 04:40AM Natera reports significant survival benefit in ALTAIR colorectal cancer trial

Dec 18, 2025 08:04AM Natera publishes colorectal cancer study results in JAMA Oncology

Dec 16, 2025 08:02AM Natera's Signatera test improves breast cancer recurrence prediction

Dec 16, 2025 03:56AM Natera (NTRA) PT Raised to $275 at Jefferies

Dec 11, 2025 10:07AM TD Cowen on Natera (NTRA): 'Management Meetings Reflect Solid Momentum With Levers for Upside'

Dec 11, 2025 03:58AM Natera's MRD test shows prognostic value in breast cancer study

Dec 8, 2025 06:42AM Canaccord Genuity Reiterates Buy Rating on Natera (NTRA)

Dec 5, 2025 08:32AM Natera (NTRA) files for 1.95M share offering by selling stockholders

Dec 5, 2025 07:00AM Natera acquires Foresight Diagnostics for up to $450 million

Dec 2, 2025 09:25AM Morgan Stanley Assumes Natera (NTRA) at Overweight

Nov 13, 2025 06:54AM Natera (NTRA) PT Raised to $235 at Stephens

Nov 7, 2025 09:13AM Natera (NTRA) PT Raised to $240 at TD Cowen

Nov 7, 2025 04:34AM Natera (NTRA) PT Raised to $250 at Evercore ISI

Nov 7, 2025 04:20AM Natera (NTRA) PT Raised to $230 at BTIG

Nov 6, 2025 04:12PM Natera (NTRA) Misses Q3 EPS by 27c; offers guidance

Oct 29, 2025 08:48AM Piper Sandler Reiterates Overweight Rating on Natera (NTRA)

Oct 28, 2025 07:01AM Natera reports blood test shows 22.5% sensitivity for precancerous polyps

Oct 27, 2025 07:30AM BNP Paribas Exane Upgrades Natera (NTRA) to Neutral

Oct 24, 2025 06:20AM Canaccord Genuity Reiterates Buy Rating on Natera (NTRA)

Oct 23, 2025 01:16PM Natera (NTRA) PT Raised to $210 at BTIG

Oct 14, 2025 06:28AM Canaccord Genuity Reiterates Buy Rating on Natera (NTRA)

Oct 1, 2025 08:01AM Natera enrollment exceeds 1,600 patients in single gene NIPT trial

Sep 30, 2025 08:01AM Natera publishes testicular cancer study showing Signatera outperforms tumor markers

Sep 29, 2025 08:04AM NATERA study shows Signatera detected all uterine cancer recurrences

Sep 22, 2025 05:27AM Wells Fargo Resumes Natera (NTRA) at Equal Weight

Sep 15, 2025 08:29AM Piper Sandler on Natera (NTRA): 'IMvigor011 Changes the Game in More Ways than Expected'

View Older Stories